Jun Lu

发表

Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy

Yan Wang, Ying Wang, S. Luo, 2022, Frontiers in Neurology.

Neutral lipid storage disease with myopathy in China: a large multicentric cohort study

Wei Zhang, Zhaoxia Wang, Yun Yuan, 2019, Orphanet Journal of Rare Diseases.

Genetic variability and clinical spectrum of Chinese patients with limb‐girdle muscular dystrophy type 2A

S. Luo, J. Xi, Chongbo Zhao, 2012, Muscle & nerve.

In‐depth peripheral CD4+ T profile correlates with myasthenic crisis

Ying Wang, S. Luo, J. Xi, 2021, Annals of clinical and translational neurology.

HLA-DQA1*03:02/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese

S. Luo, B. Xiao, J. Xi, 2012, Journal of Neuroimmunology.

Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective

H. Lv, Wei Zhang, Zhaoxia Wang, 2020, Journal of Medical Genetics.

5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy.

Xilu Wang, T. Dou, S. Luo, 2020, Brain : a journal of neurology.

Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets

S. Luo, J. Xi, Chongbo Zhao, 2021, Journal of Neuroimmunology.

Short‐term effect of low‐dose rituximab on myasthenia gravis with muscle‐specific tyrosine kinase antibody

Yufan Zhou, S. Luo, J. Xi, 2021, Muscle & nerve.

Novel mutations m.3959G>A and m.3995A>G in mitochondrial gene MT-ND1 associated with MELAS

Duan Ma, S. Luo, Hui-jun Wang, 2014, Mitochondrial DNA.

Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis

Wenhui Li, J. Xi, Chongbo Zhao, 2017, Journal of Neurology.

Multiple Mongolian spots in an individual with Kleefstra syndrome caused by a novel nonsense euchromatin histone methyltransferase 1 variant

Jun Lu, X. Pan, 2022, Clinical dysmorphology.

Giant cell polymyositis associated with myasthenia gravis and thymoma

W. Fang, S. Luo, Chongbo Zhao, 2014, Journal of Clinical Neuroscience.

Predictive Score for In-Hospital Mortality of Myasthenic Crisis: A Retrospective Chinese Cohort Study

Lei Zhou, S. Luo, J. Xi, 2019, European Neurology.

Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis

C. Quan, S. Luo, J. Xi, 2019, Journal of Neuroimmunology.

Low‐dose rituximab every 6 months for the treatment of acetylcholine receptor–positive refractory generalized myasthenia gravis

J. Xi, Liang Wang, Huahua Zhong, 2019, Muscle & nerve.

Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients

S. Luo, J. Xi, Huahua Zhong, 2020, Journal of Neuroimmunology.

Isaacs syndrome with CASPR2 antibody: A series of three cases

C. Quan, J. Xi, Jie Song, 2017, Journal of Clinical Neuroscience.

Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China

S. Luo, J. Xi, Hui Wu, 2020, European Neurology.

A series of Chinese patients with desminopathy associated with six novel and one reported mutations in the desmin gene

Wei Zhang, X. Luan, J. Lu, 2011, Neuropathology and applied neurobiology.

Deep Pathological Phenotyping of Dermatomyositis with Different Autoantibodies

B. Bu, S. Luo, J. Xi, 2021 .

A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab

S. Luo, J. Xi, X. Huan, 2024, CNS neuroscience & therapeutics.